![](https://2c717466dc25cd7041c9-8eeda6a8ca964cf210ed223dbc947813.ssl.cf2.rackcdn.com/19730793-668797677-cvrx-outsmart-the-heart-logo-rgb-blue-png-100x40.png)
CVRx to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call on July 29th, 2024
MINNEAPOLIS, July 15, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing Barostim™, an innovative extravascular implantable neuromodulation device …